Clinical Trials Browser

Terminated × nimotuzumab × Gastrointestinal × Clear all

NCT01813253 2018-03-26

Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer

Phase 3 Terminated

Gastrointestinal

Stomach Neoplasms

NCT01382745 2013-01-28

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Phase 2 Terminated

Gastrointestinal

Squamous Cell Carcinoma of Anal Canal